Role of the Lipid-regulated NF-κB/IL-6/STAT3 Axis in Alpha-naphthyl Isothiocyanate-induced Liver Injury
Overview
Authors
Affiliations
Alpha-naphthyl isothiocyanate (ANIT)-induced liver damage is regarded as a useful model to study drug-induced cholestatic hepatitis. Ultra-performance liquid chromatography coupled with electrospray ionization quadrupole mass spectrometry (UPLC-ESI-QTOF MS)-based metabolomics revealed clues to the mechanism of ANIT-induced liver injury, which facilitates the elucidation of drug-induced liver toxicity. 1-Stearoyl-2-hydroxy-sn-glycero-3-phosphocholine (LPC 18:0) and 1-oleoyl-2-hydroxy-sn-glycero-3-phosphocholine (LPC 18:1) were significantly increased in serum from ANIT-treated mice, and this increase resulted from altered expression of genes encoding the lipid metabolism enzymes Chka and Scd1. ANIT also increased NF-κB/IL-6/STAT3 signaling, and in vitro luciferase reporter gene assays revealed that LPC 18:0 and LPC 18:1 can activate NF-κB in a concentration-dependent manner. Activation of PPARα through feeding mice a Wy-14,643-containing diet (0.1%) reduced ANIT-induced liver injury, as indicated by lowered ALT and AST levels, and liver histology. In conclusion, the present study demonstrated a role for the lipid-regulated NF-κB/IL-6/STAT3 axis in ANIT-induced hepatotoxicity, and that PPARα may be a potential therapeutic target for the prevention of drug-induced cholestatic liver injury.
Tan L, Ouyang Z, Chen Z, Sun F, Guo H, Wang F Lipids Health Dis. 2023; 22(1):12.
PMID: 36698175 PMC: 9875463. DOI: 10.1186/s12944-023-01777-4.
Li W, Chen H, Qian Y, Wang S, Luo Z, Shan J Front Pharmacol. 2022; 13:907271.
PMID: 35754480 PMC: 9213752. DOI: 10.3389/fphar.2022.907271.
Li J, Chen X, Zhou C, Fang W, Lv W, Cheng D World J Gastrointest Surg. 2021; 13(11):1448-1462.
PMID: 34950433 PMC: 8649562. DOI: 10.4240/wjgs.v13.i11.1448.
Wang C, Peng F, Zhong B, Shi Y, Wang X, Jin X Front Pharmacol. 2021; 12:732478.
PMID: 34776958 PMC: 8585842. DOI: 10.3389/fphar.2021.732478.
Wang D, Yu H, Li Y, Xu Z, Shi S, Dou D Exp Ther Med. 2021; 22(3):1014.
PMID: 34373700 PMC: 8343461. DOI: 10.3892/etm.2021.10446.